Roche presents phase III Lucentis results in patients with retinal vein occlusion Aug. 4, 2009 No Comments
Sylentis receives approval to begin phase I studies with its antiglaucoma agent SYL-040012 July 27, 2009 No Comments
Foresight reports results from a pilot study of FST-100 in viral conjunctivitis July 23, 2009 No Comments
RSS